Ann: Appendix 4C and Commentary-MLA.AX, page-3

I liked it, finally some clean numbers.

+ No debt
+ Cash in bank almost doubled to 608k
+ On track to post a profit for the year - annualised would be >1mill which would give MLA a PE of 7ish.
+ New product launch next month (May) - Clements in the portable suction device range.
+ Company is evaluating further opportunities to add to their existing product range

- Revenue dropped back a bit further than I thought when taking into account the Medivet contribution, however when reviewing past quarters, March has typically been the weakest - as they mentioned. Yoy growth is still trending in the right direction (+7.2%)


Another report similar to this (or better!) and MLA might start flagging on a Radar or two. Not many profitable companies with +12m Revenue trading at a Mcap of $7m, I filter the Asx for medical and tech stocks constantly and keep using MLA as a comparison, hard to want to diversify when other investments don't look nearly as good.


IMO, DYOR etc...